Rojas, Ruperta .
HRN: 27-08-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2025
CEFTRIAXONE 1G (VIAL)
05/10/2025
05/17/2025
IV
2 Gram
OD
VAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes